A Model-Free Approach to Automatic Dose Guidance in Long Acting Insulin Treatment of Type 2 Diabetes

This letter presents a model-free insulin titration algorithm for patients with type 2 diabetes that automatically finds and maintains the optimal insulin dosage in order to maintain the blood glucose concentration at desired levels. The proposed method is based on recursive least square-based extremum seeking control. Since the proposed method does not require a detailed model, it can be applied on a wide population of patients without the need to identify and adapt models to the patient data. We demonstrate the effectiveness of the proposed method using in silico simulations, which are benchmarked against two standard-of-care approaches. We also show that the proposed method can handle intra-patient metabolic variations and non-adherence to the treatment regimen. Finally, using a population of 50 virtual patients, we show that the proposed method is able to handle inter-patient variations.

[1]  Eyal Dassau,et al.  Extremum Seeking Control for Personalized Zone Adaptation in Model Predictive Control for Type 1 Diabetes , 2018, IEEE Transactions on Biomedical Engineering.

[2]  Ali Cinar,et al.  Adaptive control of artificial pancreas systems - a review. , 2014, Journal of healthcare engineering.

[3]  Eyal Dassau,et al.  Periodic-Zone Model Predictive Control for Diurnal Closed-Loop Operation of an Artificial Pancreas , 2013, Journal of diabetes science and technology.

[4]  Niels Kjølstad Poulsen,et al.  Modelling of glucose-insulin dynamics from low sampled data , 2018 .

[5]  J. B. Jørgensen,et al.  Model predictive control for dose guidance in long acting insulin treatment of type 2 diabetes , 2019, IFAC J. Syst. Control..

[6]  J. B. Jørgensen,et al.  Nonlinear Model Predictive Control for an Artificial β-cell , 2010 .

[7]  Garry M. Steil,et al.  Identification of Intraday Metabolic Profiles during Closed-Loop Glucose Control in Individuals with Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[8]  Niels Kjølstad Poulsen,et al.  Modelling of fasting glucose-insulin dynamics from sparse data* , 2018, 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[9]  R. Hovorka,et al.  Coming of age: the artificial pancreas for type 1 diabetes , 2016, Diabetologia.

[10]  Alex Simpkins,et al.  System Identification: Theory for the User, 2nd Edition (Ljung, L.; 1999) [On the Shelf] , 2012, IEEE Robotics & Automation Magazine.

[11]  L. Magni,et al.  Diabetes: Models, Signals, and Control , 2010, IEEE Reviews in Biomedical Engineering.

[12]  L. Magni,et al.  Model Predictive Control of Type 1 Diabetes: An in Silico Trial , 2007, Journal of diabetes science and technology.

[13]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.

[14]  T. Kadowaki,et al.  Insulin degludec in a simple or stepwise titration algorithm in a Japanese population of patients with type 2 diabetes: a randomized, 26-week, treat-to-target trial , 2017, Diabetology International.

[15]  John Leth,et al.  Glucose-Insulin Dynamical Model for Type 2 Diabetic Patients , 2020, ArXiv.

[16]  The Padova Type 2 Diabetes Simulator from Triple-Tracer Single Meal Studies: In Silico Trials also possible in Rare but Not-So-Rare Individuals. , 2020, Diabetes technology & therapeutics.

[17]  Roman Hovorka,et al.  Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. , 2017, The lancet. Diabetes & endocrinology.